172 related articles for article (PubMed ID: 10764734)
1. Aging fibroblasts present reduced epidermal growth factor (EGF) responsiveness due to preferential loss of EGF receptors.
Shiraha H; Gupta K; Drabik K; Wells A
J Biol Chem; 2000 Jun; 275(25):19343-51. PubMed ID: 10764734
[TBL] [Abstract][Full Text] [Related]
2. IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity.
Shiraha H; Glading A; Gupta K; Wells A
J Cell Biol; 1999 Jul; 146(1):243-54. PubMed ID: 10402474
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor.
Swindle CS; Tran KT; Johnson TD; Banerjee P; Mayes AM; Griffith L; Wells A
J Cell Biol; 2001 Jul; 154(2):459-68. PubMed ID: 11470832
[TBL] [Abstract][Full Text] [Related]
4. Aging-related attenuation of EGF receptor signaling is mediated in part by increased protein tyrosine phosphatase activity.
Tran KT; Rusu SD; Satish L; Wells A
Exp Cell Res; 2003 Oct; 289(2):359-67. PubMed ID: 14499637
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement.
Chen P; Xie H; Sekar MC; Gupta K; Wells A
J Cell Biol; 1994 Nov; 127(3):847-57. PubMed ID: 7962064
[TBL] [Abstract][Full Text] [Related]
6. Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization.
Liu Y; Li R; Ladisch S
J Biol Chem; 2004 Aug; 279(35):36481-9. PubMed ID: 15215248
[TBL] [Abstract][Full Text] [Related]
7. Desmoglein 3 gene mediates epidermal growth factor/epidermal growth factor receptor signaling pathway involved in inflammatory response and immune function of anaphylactic rhinitis.
Ri H; Peiyan Z; Jianqi W; Yunteng Z; Gang L; Baoqing S
Biomed Pharmacother; 2019 Oct; 118():109214. PubMed ID: 31382129
[TBL] [Abstract][Full Text] [Related]
8. Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells.
Xu KP; Ding Y; Ling J; Dong Z; Yu FS
Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):813-20. PubMed ID: 14985295
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of aquaporin-3 and epidermal growth factor receptor expression and activation in systemic sclerosis dermal fibroblasts.
Farhadi E; Mahmoudi M; Rahmani F; Yousefi B; Sarafnejad A; Kavosi H; Karimizadeh E; Jamshidi A; Gharibdoost F
J Cell Physiol; 2019 Aug; 234(8):12876-12883. PubMed ID: 30536805
[TBL] [Abstract][Full Text] [Related]
10. Mathematical model for the effects of epidermal growth factor receptor trafficking dynamics on fibroblast proliferation responses.
Starbuck C; Lauffenburger DA
Biotechnol Prog; 1992; 8(2):132-43. PubMed ID: 1368006
[TBL] [Abstract][Full Text] [Related]
11. Gene 33 is an endogenous inhibitor of epidermal growth factor (EGF) receptor signaling and mediates dexamethasone-induced suppression of EGF function.
Xu D; Makkinje A; Kyriakis JM
J Biol Chem; 2005 Jan; 280(4):2924-33. PubMed ID: 15556944
[TBL] [Abstract][Full Text] [Related]
12. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor.
Kalmes A; Vesti BR; Daum G; Abraham JA; Clowes AW
Circ Res; 2000 Jul; 87(2):92-8. PubMed ID: 10903991
[TBL] [Abstract][Full Text] [Related]
13. Retinoids suppress epidermal growth factor-associated cell proliferation by inhibiting epidermal growth factor receptor-dependent ERK1/2 activation.
Sah JF; Eckert RL; Chandraratna RA; Rorke EA
J Biol Chem; 2002 Mar; 277(12):9728-35. PubMed ID: 11788593
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
[TBL] [Abstract][Full Text] [Related]
15. Contact inhibitory Eph signaling suppresses EGF-promoted cell migration by decoupling EGFR activity from vesicular recycling.
Stallaert W; Brüggemann Y; Sabet O; Baak L; Gattiglio M; Bastiaens PIH
Sci Signal; 2018 Jul; 11(541):. PubMed ID: 30065026
[TBL] [Abstract][Full Text] [Related]
16. Elastase-released epidermal growth factor recruits epidermal growth factor receptor and extracellular signal-regulated kinases to down-regulate tropoelastin mRNA in lung fibroblasts.
DiCamillo SJ; Carreras I; Panchenko MV; Stone PJ; Nugent MA; Foster JA; Panchenko MP
J Biol Chem; 2002 May; 277(21):18938-46. PubMed ID: 11889128
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo.
Lang SA; Klein D; Moser C; Gaumann A; Glockzin G; Dahlke MH; Dietmaier W; Bolder U; Schlitt HJ; Geissler EK; Stoeltzing O
Mol Cancer Ther; 2007 Mar; 6(3):1123-32. PubMed ID: 17363505
[TBL] [Abstract][Full Text] [Related]
18. EGF receptor.
Wells A
Int J Biochem Cell Biol; 1999 Jun; 31(6):637-43. PubMed ID: 10404636
[TBL] [Abstract][Full Text] [Related]
19. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
20. Cell surface restriction of EGFR by a tenascin cytotactin-encoded EGF-like repeat is preferential for motility-related signaling.
Iyer AK; Tran KT; Griffith L; Wells A
J Cell Physiol; 2008 Feb; 214(2):504-12. PubMed ID: 17708541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
